This content is machine translated Non-small cell lung cancer Molecular diagnostics under the microscope To date, molecular testing in non-small cell lung cancer (NSCLC) has been reserved primarily for stage IV patients. However, with the introduction of targeted therapies also in earlier tumor stages,…
